Baker Brothers Advisors - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 123 filers reported holding RELMADA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$18,329,000
+94.9%
495,1130.0%0.12%
+126.4%
Q2 2022$9,402,000
-29.6%
495,1130.0%0.05%
-31.2%
Q1 2022$13,363,000
+19.8%
495,1130.0%0.08%
+42.6%
Q4 2021$11,155,000
+111.8%
495,113
+146.3%
0.05%
+134.8%
Q3 2021$5,268,000
+114.8%
200,996
+162.4%
0.02%
+109.1%
Q2 2021$2,452,00076,6000.01%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders